Biotech Stock Review. Citius, CTXR

More Great News From Citius Pharma (CTXR).

UPDATED CHART 6-15-21 Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News
Auris Medical, Altamira Therapeutics

Adding Auris Medical (EARS) $3.50 to Biotech Watch List.

Auris Medical soared 590% in one Week on Covid Related News on December 1st, 2020. LIFT OFF...
Aphex Biocleanse Systems

Aphex BioCleanse Further Expands Distribution Channels.

Aphex BioCleanse Systems Announces Partnership With Bifulco Consulting Group to Expand Distribution Channels PITTSFORD, N.Y., May 20, 2021...

Citius Pharma (CTXR) Updates Shareholders.

Citius Update Stem Cell Study Citius Pharmaceuticals, Inc announced that it will present a poster at the International Society...
Dermaphex

Aphex BioCleanse System’s (SNST) Significant Hand Sanitizer Purchase Order.

Aphex BioCleanse Systems Announces Significant Purchase Order for Proprietary, Alcohol-Free Hand Sanitizer Product PITTSFORD, N.Y. , May 4, 2021 /PRNewswire/ -- Aphex...

Stem Cell Play Organicell (BPSR) Screams Higher.

Stock Levitates After Series of Positive Press Releases on Zofrin. Added to the Watch List in April a...
Citius, Leonard Mazur

Interview: Citius Pharma (CTXR) $1.74, Chairman Leonard Mazur.

https://youtu.be/vMIy8xWLOKI?t=3699 Starts at 1 Hour Mark. INSIDER HOLDINGS

Bill Gates Warns That a Next Pandemic Could Be 10 Times Worse.

Well Alrighty Then. Just as we Were Starting to Get Comfortable Sitting on a Barstool Again.. The Microsoft co-founder...
Citius, Biotech Stock Review

Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

The 2021 Biotech Six Pack, Six Stocks We Expect to Double. We're still putting the 2021 list together now,...

Make Hay While the Sun Shines. Up 6,400%.

Celcius (CELH) We're Up 6,400%. Alkaline Water (WTER) We're Up 12%.Dicerna (DRNA) We're Up 700%. Ready to Breakout?BioSig (BSGM) We Have...

Latest article

Smart for Life (SMFL) Capitulates?

We Are Long Term Bullish on Smart for Life. After a Volatile Post IPO Trading, we may Have Seen the Bottom....

Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become...

Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)

Great call. This was actually from Late 2018. (Bloomberg) — Billionaire investor Michael Novogratz is resolute when it...